SAMSARA THERAPEUTICS
Samsara Therapeutics, Inc. is an R&D-stage biopharmaceutical platform company aiming to discover, develop and commercialize therapeutics for the treatment of unmet medical needs and age-related diseases. Samsara's platform is a pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend a healthy lifespan.
SAMSARA THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science Pharmaceutical
Founded:
2018-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.samsaratherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
13.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Employees Featured
Founder
Investors List
Longevitytech.fund
Longevitytech.fund investment in Series A - Samsara Therapeutics
Korify Capital AG
Korify Capital AG investment in Series A - Samsara Therapeutics
Apollo Health Ventures
Apollo Health Ventures investment in Seed Round - Samsara Therapeutics
Apollo Health Ventures
Apollo Health Ventures investment in Seed Round - Samsara Therapeutics
FJ Labs
FJ Labs investment in Seed Round - Samsara Therapeutics
Official Site Inspections
http://www.samsaratherapeutics.com Semrush global rank: 3.45 M Semrush visits lastest month: 4.41 K
- Host name: 191.0.153.160.host.secureserver.net
- IP address: 160.153.0.191
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Samsara Therapeutics"
Samsara Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Samsara Therapeutics, Inc. is an R&D-stage biopharmaceutical platform company aiming to discover, develop …See details»
Samsara Therapeutics - LinkedIn
Samsara Therapeutics will be represented at the 2024 Global CMT Research Convention this week in Boston. Timothy Piser, PhD, Head of R&D, will be presenting on "Small Molecule Modulators of a ...See details»
Samsara Therapeutics - The Org
Samsara Therapeutics, Inc. is a biopharmaceutical company aiming to discover the first-in-class therapeutics that treat rare genetic and neurodegenerative diseases and extend a healthy …See details»
Samsara Therapeutics - VentureRadar
"Samsara Therapeutics is an autophagy company, dedicated completely to harnessing the power of this fundamental biological process to create therapies that reduce the burden of serious …See details»
Samsara Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.samsaratherapeutics.com. Startups | Holding Company | 2018 | Massachusetts, United States | 10-50 | www.samsaratherapeutics.com. Last update 07 Mar 2025. Overview. Pipeline. …See details»
Leadership - Samsara Therapeutics
Dr. Timothy Piser is a neuropharmacologist with more than 25 years of experience leading neuroscience drug discovery and development in large public pharmaceutical companies and …See details»
Samsara Therapeutics - Overview, News & Similar companies
Jan 6, 2022 Samsara Therapeutics contact info: Phone number: (617) 413-8733 Website: www.samsaratherapeutics.com What does Samsara Therapeutics do? Samsara was founded …See details»
Samsara Therapeutics - Craft
Samsara Therapeutics has 5 employees at their 1 location and $3.2 m in total funding,. See insights on Samsara Therapeutics including office locations, competitors, revenue, financials, …See details»
Samsara Therapeutics - Company Profile - Tracxn
Feb 25, 2025 Samsara Therapeutics - Developer of therapeutics to treat neurodegenerative and rare genetic diseases. Raised funding over 1 round from 7 investors. Founded by Sebastian …See details»
SAMSARA THERAPEUTICS LTD - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SAMSARA THERAPEUTICS LTD of OXFORD. Get the latest business insights from Dun & Bradstreet.See details»
Samsara Therapeutics - PitchBook
Samsara Therapeutics General Information Description. Developer of therapeutics drug designed for the treatment of unmet medical needs and age-related diseases. The company creates a …See details»
Samsara Therapeutics - LeadIQ
CMT Research Foundation, INC. invested into Samsaratherapeutics on Nov 6th '22. ATLANTA (October 13, 2022) The CMT Research Foundation (CMTRF), a non-profit focused solely on …See details»
Samsara Therapeutics Establishes Scientific Advisory Board
Jan 6, 2022 For more information about Samsara’s SAB, please visit: www.samsaratherapeutics.com Contacts Media: Michelle Ricketts PhD Zyme …See details»
Samsara Therapeutics – Funding, Valuation, Investors, News
Samsara Therapeutics, Inc. is biopharmaceutical company aiming to discover first-in-class therapeutics that treat rare genetic and neurodegenerative disease, and extend healthy …See details»
Samsara Therapeutics - VentureRadar
Samsara Therapeutics is an autophagy company, dedicated completely to harnessing the power of this fundamental biological process to create therapies... ... Find out ...See details»
Samsara Therapeutics Closes Seed Round Led by Apollo Ventures
Feb 26, 2019 For more information, please visit www.samsaratherapeutics.com About Apollo Ventures Apollo Ventures is a life science venture capital firm and company builder working …See details»
Samsara Therapeutics Inc | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Samsara Therapeutics | CMT Research Foundation
NEWSLETTER SIGNUP Stay up to date on new CMT research, treatments and clinical trialsSee details»
New study results reinforce TAGRISSO® (osimertinib) as the …
3 days ago New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO ® (osimertinib), as …See details»
Samsara Therapeutics | VentureRadar
Website: https://www.samsaratherapeutics.com/ Develops molecules targeting the aging process, aiming to extend healthy lifespan and treat age-related diseases like ...See details»